ASCEND BY NTHRYS
Research Abroad Products

Genetics Project Topics

Browse all focused areas across all project categories under this field.

Showing 1561–1572 of 2020 project topics
Ankylosing Spondylitis HLA-B27 and GWAS Genetics
Characterizing HLA-B27 and non-HLA genetic variants contributing to ankylosing spondylitis susceptibility and studying genetic overlap with other SpA conditions.
Genetic Architecture of Common Inflammatory Diseases Click to view more details →
Multiple Sclerosis HLA and Complement Genetics
Investigating HLA-DRB1*15:01 and complement pathway variants in MS susceptibility and studying their roles in disease heterogeneity.
Genetic Architecture of Common Inflammatory Diseases Click to view more details →
Celiac Disease HLA-DQ2/DQ8 Genetic Testing
Developing HLA-DQ2 and DQ8 molecular testing for celiac disease genetic susceptibility assessment in at-risk family members and ambiguous cases.
Genetic Architecture of Common Inflammatory Diseases Click to view more details →
Sjögren Syndrome Genetic Risk Factor Studies
Conducting GWAS and family studies for identifying genetic risk loci predisposing to primary Sjögren syndrome and studying genetic overlap with SLE.
Genetic Architecture of Common Inflammatory Diseases Click to view more details →
Rheumatoid Arthritis SNP Panel Diagnostic SaaS Platform
A cloud-based diagnostic platform that integrates multi-locus SNP genotyping with machine learning algorithms to predict RA risk and treatment response in clinical settings. This B2B solution generates recurring revenue through laboratory licensing fees and improves patient stratification for pharmaceutical companies developing targeted biologics.
Genetic Architecture of Common Inflammatory Diseases Click to view more details →
Inflammatory Bowel Disease Genetic Risk Stratification Software
An enterprise software tool that combines GWAS data with clinical phenotyping to stratify Crohn''s disease and ulcerative colitis patients into precision medicine cohorts. The platform enables payers and healthcare systems to reduce treatment costs through early intervention and optimized drug selection, creating direct cost-saving revenue models.
Genetic Architecture of Common Inflammatory Diseases Click to view more details →
Type 1 Diabetes Polygenic Risk Score Screening Tool
A commercial screening application that calculates individualized polygenic risk scores for type 1 diabetes susceptibility using genome-wide variant panels. The tool targets pediatric healthcare networks and endocrinology clinics with subscription-based access, enabling early preventive interventions and generating B2B recurring revenue.
Genetic Architecture of Common Inflammatory Diseases Click to view more details →
Systemic Lupus Erythematosus Genetic Biomarker Discovery Platform
A proprietary bioinformatics platform that identifies novel SLE-associated genetic variants through population-scale GWAS and integrates immunological pathway analysis for drug target identification. This platform monetizes through licensing agreements with pharmaceutical companies seeking to validate therapeutic targets and accelerate drug development pipelines.
Genetic Architecture of Common Inflammatory Diseases Click to view more details →
Psoriasis HLA and IL-23 Pathway Genetic Testing Suite
A comprehensive genetic testing and reporting suite that combines HLA typing with IL-23 pathway variant analysis to predict biologic therapy response in psoriasis patients. The service captures value through direct-to-consumer testing, dermatology clinic partnerships, and pharmaceutical outcome tracking agreements that improve drug efficacy reporting.
Genetic Architecture of Common Inflammatory Diseases Click to view more details →
Vasculitis Genetic Classification Engine for Precision Treatment
An AI-powered clinical decision support engine that integrates ANCA-associated and other vasculitis genetic signatures to enable rapid molecular classification and personalized treatment recommendations. The platform generates revenue through hospital system integration, clinical trial patient enrichment services, and real-world evidence data licensing to pharmaceutical sponsors.
Genetic Architecture of Common Inflammatory Diseases Click to view more details →
Pompe Disease GAA Gene Variant Classification
Classifying GAA pathogenic variants for predicting late-onset versus classic infantile Pompe disease phenotype and enzyme replacement therapy response.
Genetic Basis of Glycogen Storage Diseases Click to view more details →
McArdle Disease PYGM Gene Testing
Characterizing PYGM variants causing McArdle disease and developing genotype-based exercise capacity and myoglobinuria risk prediction.
Genetic Basis of Glycogen Storage Diseases Click to view more details →